Cargando…

Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection

Solitary large hepatocellular carcinoma (SLHCC) is a specific subtype of HCC with unique characteristics. It is of great interest to assess and stratify the prognosis of SLHCCs after curative resection. In this study, we tried to construct a prognostic nomogram for SLHCC following curative resection...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Hongkai, Zhou, Zixuan, Ma, Zuyi, Huang, Shanzhou, Gong, Yuanfeng, Zhang, Zedan, Hou, Baohua, Yu, Weixuan, Zhang, Chuanzhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703492/
https://www.ncbi.nlm.nih.gov/pubmed/33312945
http://dx.doi.org/10.3389/fonc.2020.556489
_version_ 1783616650122100736
author Zhuang, Hongkai
Zhou, Zixuan
Ma, Zuyi
Huang, Shanzhou
Gong, Yuanfeng
Zhang, Zedan
Hou, Baohua
Yu, Weixuan
Zhang, Chuanzhao
author_facet Zhuang, Hongkai
Zhou, Zixuan
Ma, Zuyi
Huang, Shanzhou
Gong, Yuanfeng
Zhang, Zedan
Hou, Baohua
Yu, Weixuan
Zhang, Chuanzhao
author_sort Zhuang, Hongkai
collection PubMed
description Solitary large hepatocellular carcinoma (SLHCC) is a specific subtype of HCC with unique characteristics. It is of great interest to assess and stratify the prognosis of SLHCCs after curative resection. In this study, we tried to construct a prognostic nomogram for SLHCC following curative resection through a retrospective analysis of 202 SLHCC cases. Seven prognostic factors were identified and integrated to establish a novel prognostic nomogram, which included tumor size, microvascular invasion, tumor differentiation, Ki67 (%), α-fetoprotein (AFP), carbohydrate antigen 125 (CA125), and HBsAg status. The Harrell's concordance index (C-index) of the nomogram for overall survival (OS) in the training, validation, and whole sets was 0.752, 0.703, and 0.733, respectively. Furthermore, the area under the curve (AUC) of the receiver operating characteristic (ROC) curve of the nomogram for predicting 1-, 3-, and 5-year OS indicated that the nomogram had an optimal discrimination of the prognostic prediction for SLHCC. The total score of each patient was calculated based on the nomogram, and patients were divided into three subgroups: low-risk group (total score ≦ 107), medium-risk group (107 < total score ≤ 125), and high-risk group (total score > 125). The 1-, 3-, and 5-year OS rates of the low-risk, medium-risk, and high-risk groups in the whole set were 89.3 vs. 70.1 vs. 33.3%, 76.6 vs. 37.8 vs. 14.5%, and 69.8 vs. 25.1 vs. 12.5%, respectively (P < 0.001). Similar results were shown in terms of the recurrence-free survival (RFS) rate. By analyzing 101 cases of recurrent tumors, transarterial chemoembolization (TACE) plus radiofrequency ablation (RFA)/surgery was found to prolong patient survival when compared to TACE alone in the low-risk group, but not in the medium/high-risk group. In conclusion, our prognostic nomogram successfully stratifies the prognosis for SLHCC after curative resection, which deserves further study in future clinical practice.
format Online
Article
Text
id pubmed-7703492
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77034922020-12-10 Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection Zhuang, Hongkai Zhou, Zixuan Ma, Zuyi Huang, Shanzhou Gong, Yuanfeng Zhang, Zedan Hou, Baohua Yu, Weixuan Zhang, Chuanzhao Front Oncol Oncology Solitary large hepatocellular carcinoma (SLHCC) is a specific subtype of HCC with unique characteristics. It is of great interest to assess and stratify the prognosis of SLHCCs after curative resection. In this study, we tried to construct a prognostic nomogram for SLHCC following curative resection through a retrospective analysis of 202 SLHCC cases. Seven prognostic factors were identified and integrated to establish a novel prognostic nomogram, which included tumor size, microvascular invasion, tumor differentiation, Ki67 (%), α-fetoprotein (AFP), carbohydrate antigen 125 (CA125), and HBsAg status. The Harrell's concordance index (C-index) of the nomogram for overall survival (OS) in the training, validation, and whole sets was 0.752, 0.703, and 0.733, respectively. Furthermore, the area under the curve (AUC) of the receiver operating characteristic (ROC) curve of the nomogram for predicting 1-, 3-, and 5-year OS indicated that the nomogram had an optimal discrimination of the prognostic prediction for SLHCC. The total score of each patient was calculated based on the nomogram, and patients were divided into three subgroups: low-risk group (total score ≦ 107), medium-risk group (107 < total score ≤ 125), and high-risk group (total score > 125). The 1-, 3-, and 5-year OS rates of the low-risk, medium-risk, and high-risk groups in the whole set were 89.3 vs. 70.1 vs. 33.3%, 76.6 vs. 37.8 vs. 14.5%, and 69.8 vs. 25.1 vs. 12.5%, respectively (P < 0.001). Similar results were shown in terms of the recurrence-free survival (RFS) rate. By analyzing 101 cases of recurrent tumors, transarterial chemoembolization (TACE) plus radiofrequency ablation (RFA)/surgery was found to prolong patient survival when compared to TACE alone in the low-risk group, but not in the medium/high-risk group. In conclusion, our prognostic nomogram successfully stratifies the prognosis for SLHCC after curative resection, which deserves further study in future clinical practice. Frontiers Media S.A. 2020-11-16 /pmc/articles/PMC7703492/ /pubmed/33312945 http://dx.doi.org/10.3389/fonc.2020.556489 Text en Copyright © 2020 Zhuang, Zhou, Ma, Huang, Gong, Zhang, Hou, Yu and Zhang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Zhuang, Hongkai
Zhou, Zixuan
Ma, Zuyi
Huang, Shanzhou
Gong, Yuanfeng
Zhang, Zedan
Hou, Baohua
Yu, Weixuan
Zhang, Chuanzhao
Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
title Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
title_full Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
title_fullStr Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
title_full_unstemmed Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
title_short Prognostic Stratification Based on a Novel Nomogram for Solitary Large Hepatocellular Carcinoma After Curative Resection
title_sort prognostic stratification based on a novel nomogram for solitary large hepatocellular carcinoma after curative resection
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7703492/
https://www.ncbi.nlm.nih.gov/pubmed/33312945
http://dx.doi.org/10.3389/fonc.2020.556489
work_keys_str_mv AT zhuanghongkai prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection
AT zhouzixuan prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection
AT mazuyi prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection
AT huangshanzhou prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection
AT gongyuanfeng prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection
AT zhangzedan prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection
AT houbaohua prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection
AT yuweixuan prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection
AT zhangchuanzhao prognosticstratificationbasedonanovelnomogramforsolitarylargehepatocellularcarcinomaaftercurativeresection